Sinovac Biotech Ltd SEC filings SVA

Sinovac Biotech Ltd has 578 filings in SEC EDGAR's recent list, going back to Jan 20, 2000. Its latest annual report, Form 20-F, was filed on Jun 5, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Aug 17, 2026. The company's fiscal year ends on December 31.

Form Description Filed Period
S-8 Employee stock plan registration Sep 4, 2013 —
424B5 Prospectus supplement Jan 28, 2010 —
F-3MEF Filing Jan 27, 2010 —
424B5 Prospectus supplement Jan 20, 2010 —
424B3 Prospectus Dec 2, 2009 —
F-3 Shelf registration (foreign issuer) Nov 18, 2009 —
S-8 Employee stock plan registration Sep 10, 2009 —
F-3 Shelf registration (foreign issuer) Aug 12, 2005 —
F-3 Shelf registration (foreign issuer) Feb 15, 2005 —
S-8 Employee stock plan registration May 12, 2004 —
F-1/A Net force f-1, amendment 4 Oct 29, 2002 —
F-1/A Net force f-1, amendment 3 Oct 21, 2002 —
F-1/A Net force f-1, amendment 2 Sep 27, 2002 —
F-1/A Net force f-1, amendment 1 Aug 22, 2002 —
F-1 Registration statement (foreign issuer) Jul 17, 2002 —

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SVA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Antigua and Barbuda
Headquarters
Beijing
SEC filer status
Accelerated filer
SEC CIK
1084201
Former names
NET FORCE SYSTEMS INC (until Jan 13, 2004)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.